Stockscreener 앱 받기
1.25
11.35%
-0.16
시간 외 거래:
1.25
전일 마감가:
$1.41
열려 있는:
$1.38
하루 거래량:
141.93K
Relative Volume:
0.53
시가총액:
$647.32K
수익:
$5,900
순이익/손실:
$-43.10M
주가수익비율:
-0.000028
EPS:
-43955.671
순현금흐름:
$-22.59M
1주 성능:
-56.75%
1개월 성능:
-72.03%
6개월 성능:
-99.86%
1년 성능:
-99.99%
1일 변동 폭
$1.21
$1.424
1주일 범위
$1.21
$2.00
52주 변동 폭
$1.21
$11,679.59
애디텍스트 Stock (ADTX) Company Profile
명칭
Aditxt Inc
전화
909-488-0844
주소
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
1.25 | 730.18K | 5,900 | -43.10M | -22.59M | -43,955.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
애디텍스트 주식(ADTX)의 최신 뉴스
IMAC Surrenders Ignite Assets; Proposed $35 Million Sale to Aditxt and $36 Million Financing - TradingView
IMAC Holdings (BACK) gives up Ignite assets to satisfy defaulted notes and links $36M ADTX preferred deal - Stock Titan
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary - Investing.com
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer - marketscreener.com
Aditxt’s cancer-therapy unit hires public company veteran Jeff Busch - Stock Titan
Aditxt acquires Ignite Proteomics to expand precision oncology capabilities - MSN
Targets Report: What are the risks of holding Aditxt Inc2026 Snapshot & Safe Swing Trade Setup Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Aditxt Finalizes Ignite Proteomics Acquisition, Strengthening Oncology Focus - The Globe and Mail
Aditxt (ADTX) Acquires Ignite Proteomics, Shares Drop 37% - GuruFocus
Aditxt Backs Acquisition of Ignite Proteomics - themiddlemarket.com
Aditxt acquires precision oncology firm Ignite Proteomics - Investing.com Nigeria
Aditxt (ADTX) Acquires Ignite Proteomics in $36M Stock Deal - GuruFocus
Aditxt Buys Ignite Proteomics for $36M in Preferred Stock and Secures $2.88M Note Financing - TradingView
Aditxt (NASDAQ: ADTX) buys Ignite Proteomics with $36M preferred stock, adds notes - Stock Titan
Aditxt acquires precision oncology firm Ignite Proteomics By Investing.com - Investing.com UK
Aditxt cancer move: Ignite Proteomics to guide therapy for 600,000 - Stock Titan
Aditxt, Inc. acquired Ignite Proteomics LLC from IMAC Holdings, Inc. and others for approximately $36 million. - marketscreener.com
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
Aditxt to implement 1-for-8 reverse stock split on March 9 - Investing.com Nigeria
ETF Watch: Does Aditxt Inc stock benefit from AI growth2025 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Aditxt Implements Reverse Stock Split to Maintain Nasdaq Listing - The Globe and Mail
Guidance Update: Is Aditxt Inc forming a bullish divergenceWall Street Watch & Weekly Watchlist of Top Performers - baoquankhu1.vn
Aditxt (ADTX) Implements 1-for-8 Reverse Stock Split - GuruFocus
Aditxt, Inc. (Nasdaq Adtx) announces 1-for-8 reverse stock split effective at the open of trading on March 9, 2026 - marketscreener.com
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 - marketscreener.com
Aditxt (NASDAQ: ADTX) sets 1-for-8 reverse stock split to support Nasdaq bid - Stock Titan
Eight Aditxt shares become one as 1-for-8 Nasdaq reverse split starts March 9 - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
VIX Spike: Can Aditxt Inc grow without dilutionTrade Analysis Summary & Technical Pattern Recognition Alerts - baoquankhu1.vn
ADTX SEC FilingsAditxt Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ADTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Comparing Aditxt (NASDAQ:ADTX) & Ernexa Therapeutics (NASDAQ:ERNA) - Defense World
ADTX Fundamental Analysis | ADITXT INC (NASDAQ:ADTX) - ChartMill
Can Aditxt Inc grow without external fundingMarket Volume Report & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Is Aditxt Inc. stock a good dividend stockJuly 2025 Setups & AI Optimized Trade Strategies - mfd.ru
Aug Update: What are the risks of holding Aditxt IncEarnings Trend Report & Smart Money Movement Alerts - baoquankhu1.vn
Does Aditxt Inc. stock benefit from AI growthJuly 2025 EndofMonth & Capital Efficient Trade Techniques - mfd.ru
Aug Momentum: Will TNL Mediagene be affected by tariffsPortfolio Risk Report & Pattern Based Trade Signal System - baoquankhu1.vn
ADTX Technical Analysis & Stock Price Forecast - Intellectia AI
Will Aditxt Inc. stock remain a Wall Street favoriteMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - mfd.ru
Aditxt Holders Approve Share Issuances, Reverse Split Flexibility - The Globe and Mail
Does Aditxt Inc. have pricing powerJuly 2025 Earnings & Verified Chart Pattern Signals - mfd.ru
ADTX PE Ratio & Valuation, Is ADTX Overvalued - Intellectia AI
Aditxt Inc. Completes Reverse Split, Stock Price Drops - Intellectia AI
Fiserv Introduces INDX, a Real-Time Cash Settlement Platform for Digital Asset Companies - The Globe and Mail
What is Aditxt Inc. s debt to equity ratioJuly 2025 Selloffs & Weekly Setup with ROI Potential - mfd.ru
Aditxt Faces Pivotal Shareholder Vote and Strategic Rebrand - AD HOC NEWS
What drives Aditxt Inc.’s stock priceOil Prices & Weekly Return Optimization Alerts - mfd.ru
Aug Intraday: Can Aditxt Inc ride the EV waveMarket Growth Report & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Aug Swings: Can Aditxt Inc ride the EV waveTrend Reversal & Weekly Top Gainers Alerts - baoquankhu1.vn
애디텍스트 (ADTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):